Acquaintance: A Novel Vector-Space N-Gram Technique for Document Categorization

Stephen Huffman,M. Damashek

Abstract:Acquaintance is the name of a novel vector-space n-gram technique for categorizing documents. The technique is completely language independent, highly garble resistant, and computationally simple. An unoptimized version of the algorithm was used to process the TREC database in a very short time.

What problem does this paper attempt to address?

Cardiac transplant and exercise cardiac rehabilitation

Ray W Squires

DOI: https://doi.org/10.1007/s10741-023-10305-6

Abstract:Cardiac transplantation is the final therapeutic option for patients with end-stage heart failure. Most patients experience a favorable functional ability post-transplant. However, episodes of acute rejection, and multiple comorbidities such as hypertension, diabetes mellitus, chronic kidney disease and cardiac allograft vasculopathy are common. The number of transplants has increased steadily over the past two decades with 3,817 operations performed in the United States in 2021. Patients have abnormal exercise physiologic responses related to surgical cardiac denervation, diastolic dysfunction, and the legacy of reduced skeletal muscle oxidative capacity and impaired peripheral and coronary vasodilatory reserve resulting from pre-transplant chronic heart failure. Cardiorespiratory fitness is below normal for most patients with a mean peak VO2 of approximately 60% of predicted for healthy persons. Cardiac transplant recipients are therefore excellent candidates for Exercise-Based Cardiac Rehabilitation (CR). CR is safe and is a recommendation of professional societies both before (pre-rehabilitation) and after transplantation. CR improves peak VO2, autonomic function, quality of life, and skeletal muscle strength. Exercise training reduces the severity of cardiac allograft vasculopathy, stroke risk, percutaneous coronary intervention, hospitalization for either acute rejection or heart failure, and death. However, there are deficits in our knowledge regarding CR for women and children. In addition, the use of telehealth options for the provision of CR for cardiac transplant patients requires additional investigation.
A Review of High-Intensity Interval Training in Heart Transplant Recipients

Kari Nytrøen,Katrine Rolid

DOI: https://doi.org/10.1097/hcr.0000000000000847

2024-03-15

Journal of Cardiopulmonary Rehabilitation and Prevention

Abstract:Objective: This review reports how exercise-based rehabilitation strategies have developed over the past decades, and it specifically focuses on the effectiveness, safety, and implementation of high-intensity interval training (HIIT). It provides an overview of the historical progression, main research findings, and considerations surrounding HIIT as the preferred exercise modality for recipients of heart transplant (HTx). Review Methods: The review includes a timeline of studies spanning from 1976-2023. The 2017 Cochrane systematic review on exercise-based cardiac rehabilitation in recipients of HTx serves as the main knowledge base (≥2015). Additionally, literature searches in PubMed/Medline and ClinicalTrials.gov have been performed, and all reviews and studies reporting the effects of moderate- to high-intensity exercise in recipients of HTx, published in 2015 or later have been screened. Summary: High-intensity interval training has gained prominence as an effective exercise intervention for recipients of HTx, demonstrated by an accumulation of performed studies in the past decade, although implementation in clinical practice remains limited. Early restrictions on HIIT in HTx recipients lacked evidence-based support, and recent research challenges these previous restrictions. High-intensity interval training results in greater improvements and benefits compared with moderate-intensity continuous training in the majority of studies. While HIIT is now regarded as generally suitable on a group level, individual assessment is still advised. The impact of HIIT involves reinnervation and central and peripheral adaptations to exercise, with variations in recipent responses, especially between de novo and maintenance recipients, and also between younger and older recipients. Long-term effects and mechanisms behind the HIIT effect warrant further investigation, as well as a focus on optimized HIIT protocols and exercise benefits.

cardiac & cardiovascular systems
Detection of changes in arterial haemoglobin saturation with the pulse oximeter.

A. Coetzee,W. Heymann

Abstract:
Abstract 9556: Effect of High Intensity Interval Training in Heart Transplant Recipients - A Randomized Controlled Trial

Kari Nytrøen,Lene Annette Rustad,Pål Aukrust,Thor Ueland,Jostein Hallén,Inger Holm,Katrine Rolid,Tove Lekva,Arnt Fiane,Jan P Amlie,Svend Aakhus,Lars Gullestad

DOI: https://doi.org/10.1161/circ.126.suppl_21.a9556

IF: 37.8

2012-11-20

Circulation

Abstract:BACKGROUND High intensity interval training (HIIT) is an efficient form of exercise training in patients with coronary heart disease and heart failure, while heart transplant (HTx) recipients, mainly because of denervation, traditionally have not been exposed to HIIT. Even if many studies have documented effect of exercise in HTx recipients, VO 2peak remain below normal: 50 to 70% of predicted. Our hypothesis was that HIIT is an applicable and safe form of exercise in heart transplant (HTx) recipients, and that it would markedly improve VO 2peak. Secondarily, we wanted to evaluate central and peripheral mechanisms behind a potential VO 2peak increase. METHODS Forty-eight clinically stable HTx recipients >18 years old and 1-8 years after HTx underwent maximal exercise testing on a treadmill, muscle strength testing, echocardiography and quality of life questionnaires. They were randomized to either exercise group (a one-year HIIT-program) or control group (usual care). RESULTS The mean±SD age was 51±16 years, 71% were male and time since HTx was 4.1±2.2 years. The mean VO 2peak difference between groups at follow-up was 3.6 [2.0, 5.2] mL/kg/min ( p< 0.001). The exercise group had achieved 89.0±17.5% of predicted VO 2peak vs. 82.5±20.0% in the control group ( p< 0.001). In addition, the exercise group improved their muscular exercise capacity significantly ( p< 0.001) and had subjectively significant better general health ( p< 0.001). There were no changes in cardiac function measured by echocardiography. CONCLUSIONS The present study documents that a long-term, partly supervised and community-based HIIT-program is an applicable, effective and safe way to improve VO 2peak , muscular exercise capacity and quality of life in HTx recipients. The results indicate that HIIT should be more frequently used among stable HTx recipients in the future.

cardiac & cardiovascular systems,peripheral vascular disease
Modern advances in heart transplantation

Pratyaksh K Srivastava,Michelle M Kittleson,Pratyaksh K. Srivastava,Michelle M. Kittleson

DOI: https://doi.org/10.1016/j.pcad.2024.01.012

IF: 11.278

2024-01-01

Progress in Cardiovascular Diseases

Abstract:Heart transplantation (HTx) is the only definitive therapy for patients with end stage heart disease. With the increasing global prevalence of heart failure, the demand for HTx has continued to grow and outpace supply. In this paper, we will review advances in the field of HTx along the clinical journey of a HTx recipient. Starting with the sensitized patient, we discuss current methods to define sensitization, and assays to help identify clinically relevant anti-HLA antibodies. Desensitization strategies targeting all levels of the adaptive immune system are discussed with emphasis on novel techniques such as anti-CD 38 blockade and use of the Immunoglobulin G-Degrading Enzyme of Streptococcus Pyogenes. We next discuss donor procurement and the resurgence of donation after circulatory death as a viable strategy to significantly and safely increase the donor pool. Post-transplant, we evaluate non-invasive surveillance techniques including gene expression profiling and donor-derived cell-free DNA. Last, we discuss the ground-breaking developments in the field of xenotransplantation.

cardiac & cardiovascular systems
Effects of high-intensity interval training on cardiac remodelling, function and coronary microcirculation in de novo heart transplant patients: a substudy of the HITTS randomised controlled trial

Muzammil Rafique,Ole Geir Solberg,Lars Gullestad,Bjørn Bendz,Klaus Murbræch,Kari Nytrøen,Katrine Rolid,Ketil Lunde

DOI: https://doi.org/10.1136/bmjsem-2022-001331

2023-07-01

BMJ Open Sport & Exercise Medicine

Abstract:Objectives High-intensity interval training (HIT) improves peak oxygen consumption (VO2peak) in de novo heart transplant (HTx) recipients. It remains unclear whether this improvement early after HTx is solely dependent on peripheral adaptations, or due to a linked chain of central and peripheral adaptations. The objective of this study was to determine whether HIT results in structural and functional adaptations in the cardiovascular system. Methods Eighty-one de novo HTx recipients were randomly assigned to participate in either 9 months of supervised HIT or standard care exercise-based rehabilitation. Cardiac function was assessed by echocardiogram and the coronary microcirculation with the index of microcirculatory resistance (IMR) at baseline and 12 months after HTx. Results Cardiac function as assessed by global longitudinal strain was significantly better in the HIT group than in the standard care group (16.3±1.2% vs 15.6±2.2%, respectively, treatment effect = –1.1% (95% CI –2.0% to –0.2%), p=0.02), as was the end-diastolic volume (128.5±20.8 mL vs 123.4±15.5 mL, respectively, treatment effect=4.9 mL (95% CI 0.5 to 9.2 mL), p=0.03). There was a non-significant tendency for IMR to indicate improved microcirculatory function (13.8±8.0 vs 16.8±12.0, respectively, treatment effect = –4.3 (95% CI –9.1 to 0.6), p=0.08). Conclusion When initiated early after HTx, HIT leads to both structural and functional cardiovascular adaptations. Trial registration number NCT01796379 .

English Else
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT

Maria Simonenko,Dominique Hansen,Josef Niebauer,Maurizio Volterrani,Stamatis Adamopoulos,Cristiano Amarelli,Marco Ambrosetti,Stefan D. Anker,Antonio Bayes‐Genis,Tuvia Ben Gal,T. Scott Bowen,Francesco Cacciatore,Giuseppe Caminiti,Elena Cavaretta,Ovidiu Chioncel,Andrew J.S. Coats,Alain Cohen‐Solal,Flavio D'Ascenzi,Carmen de Pablo Zarzosa,Andreas B. Gevaert,Finn Gustafsson,Hareld Kemps,Loreena Hill,Tiny Jaarsma,Ewa Jankowska,Emer Joyce,Nicolle Krankel,Mitja Lainscak,Lars H. Lund,Brenda Moura,Kari Nytrøen,Elena Osto,Massimo Piepoli,Luciano Potena,Amina Rakisheva,Giuseppe Rosano,Gianluigi Savarese,Petar M. Seferovic,David R. Thompson,Thomas Thum,Emeline M. Van Craenenbroeck

DOI: https://doi.org/10.1002/ejhf.3185

2024-06-20

European Journal of Heart Failure

Abstract:Little is known either about either physical activity patterns, or other lifestyle‐related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines or position papers highlighting the features of prevention and rehabilitation after HTx. The aims of this scientific statement are (i) to explain the importance of prevention and rehabilitation after HTx, and (ii) to promote the factors (modifiable/non‐modifiable) that should be addressed after HTx to improve patients' physical capacity, quality of life and survival. All HTx team members have their role to play in the care of these patients and multidisciplinary prevention and rehabilitation programmes designed for transplant recipients. HTx recipients are clearly not healthy disease‐free subjects yet they also significantly differ from heart failure patients or those who are supported with mechanical circulatory support. Therefore, prevention and rehabilitation after HTx both need to be specifically tailored to this patient population and be multidisciplinary in nature. Prevention and rehabilitation programmes should be initiated early after HTx and continued during the entire post‐transplant journey. This clinical consensus statement focuses on the importance and the characteristics of prevention and rehabilitation designed for HTx recipients.

cardiac & cardiovascular systems
Survival, function, and immune profiling after beating heart transplantation

Aravind Krishnan,Stefan Elde,Chawannuch Ruaengsri,Brandon A Guenthart,Yuanjia Zhu,Moeed Fawad,Anson Lee,Maria Currie,Michael R Ma,William Hiesinger,Yasuhiro Shudo,John Ward MacArthur,Y Joseph Woo

DOI: https://doi.org/10.1016/j.jtcvs.2024.07.058

2024-08-05

Abstract:Objective: Ex vivo normothermic perfusion of cardiac allografts has expanded the donor pool for heart transplant. Using a beating heart implantation method avoids the second cardioplegic arrest and subsequent ischemia-reperfusion injury typically associated with ex vivo heart perfusion. We sought to describe our institutional experience with beating heart transplantation. Methods: This was a single-institution retrospective study of adult patients who underwent heart transplantation using ex vivo heart perfusion (EVHP) and a beating heart implantation technique between October 2022 and March 2024. Primary outcomes of interest included survival, initiation of mechanical circulatory support, and rejection. A subanalysis of our institutional series of nonbeating deceased after circulatory death (DCD) heart transplantations was performed as well. Results: Twenty-four patients underwent isolated heart transplantation with the use of ex vivo heart perfusion and beating heart implantation between October 2022 and March 2024; 21 (87.5%) received hearts from DCD donors, and 3 (12.5%) received hearts from deceased after brain death (DBD) donors. The median duration of follow-up was 192 days (interquartile range [IQR], 124-253.5 days), and 23 out of 24 patients (95.8%) were alive at last follow-up. No patients required initiation of mechanical circulatory support. The majority of patients had pathologic grade 0 rejection at the time of biopsy (n = 16; 66.7%), and the median cell-free DNA percent was 0.04% (IQR, 0.04%-0.09%). The rate of mechanical circulatory support initiation in the 22-patient nonbeating DCD heart transplant cohort was significantly higher, at 36.4% (P < .005). Conclusions: A beating heart implantation technique can be used for transplantation of DCD and DBD hearts on EVHP and is associated with excellent survival and low levels of rejection.
Cardiac Rehabilitation to Inpatient Heart Transplant-HRN4HTx Intervention Protocol

Maria Loureiro,Vítor Parola,João Duarte,Isabel Oliveira,Margarida Antunes,Gonçalo Coutinho,Maria Manuela Martins,André Novo

DOI: https://doi.org/10.3390/nursrep14030155

2024-08-23

Abstract:Heart transplantation is the gold-standard treatment for terminal heart failure. Despite being successful, pre- and post-transplant limitations interfere with patients' functional capacity, self-care, and quality of life post-surgery. Rehabilitation is necessary to address these limitations, prevent complications, and promote a safe return home. This study analyzes the safety of a phase 1 cardiac rehabilitation protocol (RN4HTx) in heart transplant patients and its effects on self-care capacity. A quantitative, descriptive study was conducted with 19 heart transplant recipients. The protocol was implemented in collaboration with a rehabilitation professional, who monitored adverse events, hemodynamic variables, self-care capacity (Barthel) pre- and post-transplant, and functional capacity at discharge (6 min walk test). The results showed that 68.42% of recipients were men, with an average age of 50.21 years and 15 days of hospitalization post-transplant. Approximately 73.68% of recipients were transferred from other wards with changes in functional capacity. All patients progressed to the final stage of the program without adverse events. There was a notable improvement in self-care capacity before and after transplantation, with a measure of functional status of 310.035 m (6MWT). The study found that RN4HTx is a feasible cardiac rehabilitation program without adverse events in the immediate postoperative period following heart transplantation, positively impacting functional recovery and therapeutic self-care capacity, thus increasing the safety of returning home. This study was retrospectively registered on Clinical Trials-NCT06552390.
Revolutionizing Heart Transplantation: A Multidisciplinary Approach to Xenotransplantation, Immunosuppression, Regenerative Medicine, Artificial Intelligence, and Economic Sustainability

Yousaf Tanveer,Aleena Arif,Tamar Tsenteradze,Nabila N Anika,Danyal Bakht,Quratulain Fatima Masood,Maryam Affaf,Wajiha Batool,Indresh Yadav,Rayan W Gasim,Youssef Mohamed,Mohamed Abdelmonim Khogali Mohamed,Chukwuyem Ekhator,Syed Naveed Mohsin,Rehman Khan

DOI: https://doi.org/10.7759/cureus.46176

2023-09-29

Cureus

Abstract:Heart transplantation (HTx) stands as a life-saving intervention for patients with end-stage heart disease, but the field is fraught with numerous challenges that span from the scarcity of donor organs to long-term complications arising from immunosuppressive therapies. This comprehensive review article offers an in-depth exploration of the multifaceted aspects of HTx. The review covers groundbreaking advancements in xenotransplantation, enabled by cutting-edge genetic engineering techniques, and the promising role of stem cell therapies, particularly porcine mesenchymal stem cells, in cardiac regeneration. It also delves into the evolution and limitations of immunosuppressive therapies and the revolutionary potential of artificial intelligence (AI) and machine learning (ML) in enhancing donor-recipient matching and predicting patient outcomes. Economic considerations, especially in the context of rising healthcare costs, are examined to assess the sustainability of these advancements. The article further discusses the significant improvements in patient outcomes over the years, while highlighting persisting challenges, such as graft failure, rejection, and infection. It underscores the importance of experience and specialized training, evidenced by the presence of an institutional learning curve. The review concludes by advocating for a multifaceted, collaborative approach involving clinicians, researchers, and policymakers to overcome existing challenges. Through coordinated efforts that consider medical, ethical, and economic factors, the field of HTx is poised for further evolution, offering renewed hope for improved patient care and outcomes.
How Would We Treat Our Own Heart Transplantation Surgery: A Perioperative Look

Oscar D Aljure,Derek Tan,Mathias Loebe,Anita Phancao,Harish Ram,Neil Mohammed,Marian Kukucka

DOI: https://doi.org/10.1053/j.jvca.2023.02.024

Abstract:Heart failure is a disease affecting 6.2 million adults in the United States, resulting in morbidity and mortality in the short and long terms. Although options such as mechanical circulatory support and transplantation are considered a solution when medical management is insufficient, heart transplantation (HTX) is regarded as the better option, with a lower incidence of multiorgan failure. A limiting step for HTX is the inadequate donor pool, so options like donation after circulatory death and xenotransplantation have emerged as alternatives. The cardiac anesthesiologist plays a pivotal role in the perioperative management of donors and recipients. A full understanding of the nature of the disease, pathophysiology, and perioperative management is paramount to the success of an HTX program. The authors include an index case to illustrate the multidisciplinary approach to the disease and the implications of managing these complex patients presenting to the operating room.
Deep phenotyping of cardiac function in heart transplant patients using cardiovascular systems models

Amanda L. Colunga,Karam G. Kim,N. Payton Woodall,Todd F. Dardas,John H. Gennari,Mette S. Olufsen,Brian E. Carlson

DOI: https://doi.org/10.1113/JP279393

2020-05-07

Journal of Physiology

Abstract:Key points Right heart catheterization (RHC) data from clinical records of heart transplant patients are used to identify patient specific models of the cardiovascular system These patient specific cardiovascular models represent a snapshot of cardiovascular function at a given post‐transplant recovery timepoint. This approach is used to describe cardiac function in ten heart transplant patients, five of which had multiple right heart catheterizations allowing an assessment of cardiac function over time. These patient predict cardiovascular function in the form of right and left ventricular pressure‐volume loops and ventricular power, an important metrics in the clinic of cardiac function. Outcomes for the longitudinally tracked patients shows that our approach was able to identify the one patient from the group of five that exhibited post‐transplant cardiovascular complications. Heart transplant patients are followed with periodic right heart catheterizations (RHCs) to identify post‐transplant complications and guide treatment. Post‐transplant positive outcomes are associated with a steady reduction of right ventricular and pulmonary arterial pressures, toward normal levels of right‐side pressure (about 20 mmHg) measured by RHC. This study shows more information about patient progression is obtained by combining standard RHC measures with mechanistic computational cardiovascular systems models. The purpose of this study is two‐fold: to understand how cardiovascular system models can be used to represent a patient's cardiovascular state, and to use these models to track post‐transplant recovery and outcome. To obtain reliable parameter estimates comparable within and across datasets, we use sensitivity analysis, parameter subset selection, and optimization to determine patient specific mechanistic parameter that can be reliably extracted from the RHC data. Patient‐specific models are identified for ten patients from their first post‐transplant RHC and longitudinal analysis is done for five patients. Results of sensitivity analysis and subset selection show we can reliably estimate seven non‐measurable quantities including ventricular diastolic relaxation, systemic resistance, pulmonary venous elastance, pulmonary resistance, pulmonary arterial elastance, pulmonary valve resistance and systemic arterial elastance. Changes in parameters and predicted cardiovascular function post‐transplant are used to evaluate cardiovascular state during recovery in five patients. Of these five patients, only one patient showed inconsistent trends during recovery in ventricular pressure‐volume relationships and power output. At the four‐year post‐transplant time point this patient exhibited biventricular failure along with graft dysfunction while the remaining four exhibited no cardiovascular complications. This article is protected by copyright. All rights reserved

neurosciences,physiology
Heart transplantation: advances in expanding the donor pool and xenotransplantation

Stephanie Jou,Sean R Mendez,Jason Feinman,Lindsey R Mitrani,Valentin Fuster,Massimo Mangiola,Nader Moazami,Claudia Gidea

DOI: https://doi.org/10.1038/s41569-023-00902-1

Abstract:Approximately 65 million adults globally have heart failure, and the prevalence is expected to increase substantially with ageing populations. Despite advances in pharmacological and device therapy of heart failure, long-term morbidity and mortality remain high. Many patients progress to advanced heart failure and develop persistently severe symptoms. Heart transplantation remains the gold-standard therapy to improve the quality of life, functional status and survival of these patients. However, there is a large imbalance between the supply of organs and the demand for heart transplants. Therefore, expanding the donor pool is essential to reduce mortality while on the waiting list and improve clinical outcomes in this patient population. A shift has occurred to consider the use of organs from donors with hepatitis C virus, HIV or SARS-CoV-2 infection. Other advances in this field have also expanded the donor pool, including opt-out donation policies, organ donation after circulatory death and xenotransplantation. We provide a comprehensive overview of these various novel strategies, provide objective data on their safety and efficacy, and discuss some of the unresolved issues and controversies of each approach.
Delta5-3beta-hydroxysteroid dehydrogenase and estradiol-17beta-hydroxysteroid dehydrogenase activity in preimplantation hamster embryos.

Z. Dickmann,J. S. Sen Gupta

IF: 3.148

Developmental Biology

Abstract:
Four Decades of Progress in Heart-Lung Transplantation: 271 Cases at a Single Institution.

Stefan Elde,Basil M. Baccouche,Danielle M. Mullis,Matthew M. Leipzig,Tobias Deuse,Aravind Krishnan,Moeed Fawad,Reid Dale,Sabrina Walsh,Amanda Padilla-Lopez,Brandon Wesley,Hao He,Shin Yajima,Yuanjia Zhu,Hanjay Wang,Brandon A. Guenthart,Yasuhiro Shudo,Bruce A. Reitz,Y. Joseph Woo

DOI: https://doi.org/10.1016/j.jtcvs.2024.01.042

IF: 6.439

2024-02-07

Journal of Thoracic and Cardiovascular Surgery

Abstract:Objective The objective of this study is to evaluate survival for combined heart-lung transplant (HLTx) recipients across four decades at a single institution. We aim to summarize our contemporary practice based upon more than 271 HLTx over 40 years. Methods Data were collected from a departmental database and the United Network for Organ Sharing (UNOS). Recipients <18y, those undergoing redo HLTx , or triple-organ system transplantation were excluded, leaving 271 patients for analysis. The Pioneering Era was defined by date of transplant between 1981-2000 (N=155), and the Modern Era between 2001-2022 (N=116). Survival analysis was performed using cardinality matching of populations based on donor and recipient age, donor and recipient sex, ischemic time, and sex-matching. Results Between 1981-2022, 271 HLTx were performed at a single institution. Recipients in the Modern Era were older (42 vs 34y, P<0.001) and had shorter waitlist times (78 vs 234d, P<0.001). Allografts from female donors were more common in the Modern Era (59% vs 39%, P=0.002). In the matched survival analysis, 30-day survival (97% vs 84%, P=0.005), 1-year survival (89% vs 77%, P=0.041), and 10-year survival (53% vs 26%, P=0.012) significantly improved in the Modern Era relative to the Pioneering Era, respectively. Conclusions Long-term survival in HLTx is achievable with institutional experience and may continue to improve in the coming decades. Advances in mechanical circulatory support, improved maintenance immunosuppression, and early recognition and management of acute complications such as primary graft dysfunction and acute rejection have dramatically improved the prognosis for HLTx recipients in our contemporary institutional experience.

surgery,cardiac & cardiovascular systems,respiratory system
Reciprocal effects of hyper- and hypoactivity mutations in the Drosophila pattern gene torso.

T. Strecker,Halsell,W. Fisher,H. Lipshitz

DOI: https://doi.org/10.1126/SCIENCE.2922596

IF: 56.9

1989-02-24

Science

Abstract:In Drosophila, five "terminal" polarity genes must be active in females in order for them to produce embryos with normal anterior and posterior ends. Hypoactivity mutations in one such gene, torso, result in the loss of the most posterior domain of fushi tarazu expression and the terminal cuticular structures. In contrast, a torso hyperactivity mutation causes the loss of central fushi tarazu expression and central cuticular structures. Cytoplasmic leakage, transplantation, and temperature-shift experiments suggest that the latter effect is caused by abnormal persistence of the torso product in the central region of the embryo during early development. Thus, the amount and timing of torso activity is key to distinguishing the central and terminal regions of the embryo. Mutations in the tailless terminal gene act as dominant maternal suppressors of the hyperactive torso allele, indicating that the torso product acts through, or in concert with, the tailless product.
Assessing the Role of Primary Heart Failure Etiology on Cardiac Transplant Outcomes

Ahad Firoz,Roh Yanagida,Mohammed Kashem,Yoshiya Toyoda,Eman Hamad

DOI: https://doi.org/10.1111/ctr.15450

Abstract:Background: There are diverse indications for heart transplantation (HTx), often categorized into ischemic (ICM) and nonischemic (NICM) cardiomyopathy. Although there is extensive research comparing the outcomes for these disease processes following certain therapeutic interventions, there are limited data on how recipient etiology impacts post-HTx survival. Our investigation seeks to identify this relationship. Methods: We conducted a retrospective analysis using adult HTx patients from the United Network for Organ Sharing database between 2000 and 2021. Patients with a combined heart-lung transplant or previous HTx were excluded. ICM included coronary artery disease (CAD) and ischemic dilated cardiomyopathy. NICM included nonischemic dilated (NIDCM), hypertrophic (HCM), and restrictive (RCM) cardiomyopathy. Overall survival was analyzed using Kaplan-Meier curves, log-rank tests, and multivariable Cox regression models. Results: A total of 42 268 patients were included in our study. Recipients with ICM were older and more likely to be males, obese, diabetics, and smokers. We found that patients with ICM had an increased incidence of transplant CAD (OR = 1.23, p < 0.001) and risk of mortality (hazard ratio [HR] = 1.22, p < 0.001) compared to NICM. When NICM was expanded, RCM had a similar hazard risk compared to ICM (HR = 1.03, p = 0.650), whereas both NIDCM (HR = 0.81, p < 0.001) and HCM (HR = 0.70, p < 0.001) had improved survival. Conclusion: Our study provides evidence to suggest that ICM has decreased survival when compared to NICM. When NICM was expanded, RCM was found to have an increased mortality risk similar to ICM, whereas NIDCM and HCM both had superior outcomes. The clinical implication of this investigation will allow clinicians to better understand the prognosis of certain patient groups.
Deficits in Pre‐ and Post‐transplant Functional, Motor, and Cognitive Deficits Associated With Graft Failure and Mortality in Pediatric Heart Transplant Recipients

Conor Donnelly,Suhani S. Patel,Teresa Po‐Yu Chiang,Luckmini Liyanage,Jane J. Long,Macey L. Levan,Manu R. Varma,Rakesh K. Singh,Dorry L. Segev,Allan B. Massie

DOI: https://doi.org/10.1111/petr.14874

2024-11-28

Pediatric Transplantation

Abstract:Pediatric HT recipients with decreased pre‐ and post‐transplant functional status are at higher risk for graft failure and mortality. These patients may benefit from early intervention aimed at improving functional status. Background Pretransplant functional, motor, cognitive, and academic deficits are common in pediatric patients requiring heart transplantation (HT); some persist post‐HT. We assessed the association between these quality of life (QoL) deficits and post‐HT outcomes. Methods Using SRTR data 2008–2023, we evaluated the functional, motor, cognitive, and academic status of pediatric HT recipients from listing to 15 years post‐HT. We compared all‐cause graft survival among patients with vs. without pre‐HT deficits using Cox regressions. Among patients with a functioning graft at 1 year, we assessed the association between deficits at that time and subsequent graft failure. Results In 6153 HT recipients, 85.3% had pre‐HT functional status ≤ 80%, 53.1% of patients could not tolerate a full academic load; this decreased to 15.2% and 15.0% postoperatively, and was sustained. Definite or probable cognitive deficits were seen in 17.4% of patients and motor delays in 18.6%; both remained stable post‐HT at 18.0% and 16.4%, respectively. Graft survival was worse in those with either pre‐ or post‐HT deficits in functional status. Worse pre‐HT functional status was associated with risk of graft failure (adjusted hazard ratio [aHR] per 10% decrease = 1.03 1.06 1.08, p

pediatrics,transplantation

Acquaintance: A Novel Vector-Space N-Gram Technique for Document Categorization

Cardiac transplant and exercise cardiac rehabilitation

A Review of High-Intensity Interval Training in Heart Transplant Recipients

Detection of changes in arterial haemoglobin saturation with the pulse oximeter.

Abstract 9556: Effect of High Intensity Interval Training in Heart Transplant Recipients - A Randomized Controlled Trial

Modern advances in heart transplantation

Effects of high-intensity interval training on cardiac remodelling, function and coronary microcirculation in de novo heart transplant patients: a substudy of the HITTS randomised controlled trial

Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT

Survival, function, and immune profiling after beating heart transplantation

Cardiac Rehabilitation to Inpatient Heart Transplant-HRN4HTx Intervention Protocol

Revolutionizing Heart Transplantation: A Multidisciplinary Approach to Xenotransplantation, Immunosuppression, Regenerative Medicine, Artificial Intelligence, and Economic Sustainability

How Would We Treat Our Own Heart Transplantation Surgery: A Perioperative Look

Deep phenotyping of cardiac function in heart transplant patients using cardiovascular systems models

Heart transplantation: advances in expanding the donor pool and xenotransplantation

Delta5-3beta-hydroxysteroid dehydrogenase and estradiol-17beta-hydroxysteroid dehydrogenase activity in preimplantation hamster embryos.

Four Decades of Progress in Heart-Lung Transplantation: 271 Cases at a Single Institution.

Reciprocal effects of hyper- and hypoactivity mutations in the Drosophila pattern gene torso.

Assessing the Role of Primary Heart Failure Etiology on Cardiac Transplant Outcomes

Deficits in Pre‐ and Post‐transplant Functional, Motor, and Cognitive Deficits Associated With Graft Failure and Mortality in Pediatric Heart Transplant Recipients